BioXpress And Abzena Partner On Biosimilar Development

Alliance Will Aid Development And Manufacturing Of Biosimilars For Global Customers

Partnership
BioXpress Therapeutics and Abzena have partnered to provide support to third party customers for developing biosimilars • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products